OPTIBIOTIX HLTH PLC LS-02
OPTIBIOTIX HLTH PLC LS-02
Share · GB00BP0RTP38 · A118S6 (XLON)
Overview Financial Indicators
0,13 GBP
0,04 % 0,00005 GBP
Closing Price XLON 06.06.2025: 13,01 GBX
London (XLON) · Current prices and charts at MoneyPeak
06.06.2025 15:13

Current Prices from OPTIBIOTIX HLTH PLC LS-02

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
OPTI.L
GBX
06.06.2025 15:13
13,01 GBX
13,18 GBX
-1,29 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -10,31 % -31,74 % -30,82 % -22,96 % -24,61 % -76,57 %

Company Profile for OPTIBIOTIX HLTH PLC LS-02 Share

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.

Company Data

Name OPTIBIOTIX HLTH PLC LS-02
Company OptiBiotix Health Plc
Website https://www.optibiotix.com
Primary Exchange XLON London
WKN A118S6
ISIN GB00BP0RTP38
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Stephen Patrick O'Hara
Market Capitalization 18 Mio
Country United Kingdom
Currency GBP
Employees 0,0 T
Address Innovation Centre, YO10 5DG York
IPO Date 2011-09-09

Stock Splits

Date Split
05.08.2014 1:200

Ticker Symbols

Name Symbol
Frankfurt OB3.F
London OPTI.L

More Shares

Investors who OPTIBIOTIX HLTH PLC LS-02 hold also have the following shares in their portfolio:
FOSSE MASTER ISSUER PLC 2019-1 CLASS Z NTS 18/10/54 (REG S)
FOSSE MASTER ISSUER PLC 2019-1 CLASS Z NTS 18/10/54 (REG S) Bond
TRANSCDA PIP. 25/65 FLR
TRANSCDA PIP. 25/65 FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025